Benitec Biopharma (BNTC) Priced

Developing a gene therapy platform based on DNA-directed RNA interference.

Health Care - Biotechnology

IPO Performance
Latest Trade $2.59 0.00 (0.0%)
First Day Return -13.5%
Return from IPO -71.9%
 
Benitec Biopharma IPO News more
  • .
IPO Data
IPO File Date 06/22/2015
Offer Price $9.21
Price Range $10.00 - $10.00
Offer Shares (mm) 1.5
Deal Size ($mm) 14
 
IPO Data
IPO Date 08/18/2015
Offer Price $9.21
Price Range $10.00 - $10.00
Offer Shares (mm) 1.5
Deal Size ($mm) $14
 
Underwriters
more
Business Overview
Developing a gene therapy platform based on DNA-directed RNA interference.
Developing a gene therapy platform based on DNA-directed RNA interference.
more
Company Data
Headquarters Balmain, , Australia
Founded 1995
Employees 21
Website www.benitec.com
 

Performance vs. IPO Index (IPOUSA)